Best for
All-rounder
How to buy The Biotech Growth Trust shares | 1600p
Own The Biotech Growth Trust shares in just a few minutes. Share price changes are updated daily.
Fact checked
The Biotech Growth Trust PLC (BIOG) is a leading asset management business based in the UK. It opened the day at 1610p after a previous close of 1588p. During the day the price has varied from a low of 1594.7971p to a high of 1612p. The latest price was 1600p (25 minute delay). The Biotech Growth Trust is listed on the London Stock Exchange (LSE). All prices are listed in pence sterling.
How to buy shares in The Biotech Growth Trust
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: BIOG in this case.
- Research The Biotech Growth Trust shares. The platform should provide the latest information available.
- Buy your The Biotech Growth Trust shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in The Biotech Growth Trust?
- Has coronavirus impacted The Biotech Growth Trust shares?
- The Biotech Growth Trust shares summary
- Compare share dealing platforms
- Is The Biotech Growth Trust stock a buy or sell?
- The Biotech Growth Trust performance over time
- Is The Biotech Growth Trust suitable for ethical investing?
- Are The Biotech Growth Trust shares over-valued?
- The Biotech Growth Trust's financials
- How volatile are The Biotech Growth Trust shares?
- Does The Biotech Growth Trust pay a dividend?
- Other common questions
How has Coronavirus impacted The Biotech Growth Trust's share price?
Since the stock market crash in March caused by coronavirus, The Biotech Growth Trust's share price has had significant positive movement.
Its last market close was 1468p, which is 32.29% up on its pre-crash value of 994p and 115.88% up on the lowest point reached during the March crash when the shares fell as low as 680p.
If you had bought £1,000 worth of The Biotech Growth Trust shares at the start of February 2020, those shares would have been worth £773.05 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,571.79.
The Biotech Growth Trust share price
Use our graph to track the performance of BIOG stocks over time.The Biotech Growth Trust shares at a glance
Information last updated 2020-12-18.
| Open | 1610p |
|---|---|
| High | 1612p |
| Low | 1594.7971p |
| Close | 1600p |
| Previous close | 1588p |
| Change | 12p |
| Change % | 0.756% |
| Volume | 91,408 |
Information last updated 2020-12-24.
| 52-week range | 680p - 1658p |
|---|---|
| 50-day moving average | 1512.4026p |
| 200-day moving average | 1356.864p |
| PE ratio | 2.28 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | 38.8p |
Invest in The Biotech Growth Trust shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy The Biotech Growth Trust stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
The Biotech Growth Trust price performance over time
Historical closes compared with the last close of 1600p
| 1 week (2021-01-08) | -2.08% |
|---|---|
| 1 month (2020-12-18) | 1600 |
| 3 months (2020-10-16) | 8.11% |
| 6 months (2020-07-17) | 18.52% |
| 1 year (2020-01-17) | 67.01% |
|---|---|
| 2 years (2019-01-17) | 125.99% |
| 3 years (2018-01-17) | 105.13% |
| 5 years (2016-01-15) | 154.78% |
Is The Biotech Growth Trust under- or over-valued?
Valuing The Biotech Growth Trust stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Biotech Growth Trust's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Biotech Growth Trust's P/E ratio
The Biotech Growth Trust's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, The Biotech Growth Trust shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Biotech Growth Trust financials
| Operating margin TTM | 105.4% |
|---|---|
| Gross profit TTM | £29 million |
| Return on assets TTM | -10.97% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | 7.431p |
| Market capitalisation | £637.5 million |
TTM: trailing 12 months
The Biotech Growth Trust's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like The Biotech Growth Trust.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
The Biotech Growth Trust's total ESG risk score
Total ESG risk: 39.63
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and The Biotech Growth Trust's overall score of 39.63 (as at 01/01/2019) is excellent – landing it in it in the 9th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like The Biotech Growth Trust is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
The Biotech Growth Trust's environmental score
Environmental score: 9/100
The Biotech Growth Trust's environmental score of 9 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that The Biotech Growth Trust is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
The Biotech Growth Trust's social score
Social score: 9/100
The Biotech Growth Trust's social score of 9 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that The Biotech Growth Trust is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
The Biotech Growth Trust's governance score
Governance score: 9/100
The Biotech Growth Trust's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that The Biotech Growth Trust is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Environmental, social, and governance (ESG) summary
The Biotech Growth Trust PLC was last rated for ESG on: 2019-01-01.
| Total ESG score | 39.63 |
|---|---|
| Total ESG percentile | 9 |
| Environmental score | 9 |
| Environmental score percentile | 9 |
| Social score | 9 |
| Social score percentile | 9 |
| Governance score | 9 |
| Governance score percentile | 9 |
The Biotech Growth Trust share dividends
We're not expecting The Biotech Growth Trust to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
The Biotech Growth Trust share price volatility
Over the last 12 months, The Biotech Growth Trust's shares have ranged in value from as little as 680p up to 1658p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while The Biotech Growth Trust's is 1.0178. This would suggest that The Biotech Growth Trust's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
The Biotech Growth Trust overview
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Transportation and Logistics Systems shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert